| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Kim Christopher | Chairman and CMO, Director | C/O APIMEDS PHARMACEUTICALS US, INC., 2 EAST BROAD STREET, 2ND FLOOR, HOPEWELL | /s/ Nelson Mullins Riley & Scarborough LLP, Attorney-in-Fact | 20 May 2025 | 0002040022 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | APUS | Common Stock, par value $0.01 per share | Award | $0 | +250,000 | +909% | $0.000000 | 277,500 | 16 May 2025 | Direct |